Modelling disorders of the brain through patient-derived stem cells

Presented by Thomas Durcan, MNI, McGill University In this presentation, we will discuss our 3D drug discovery pipeline, in which we focus on translating findings from 2D neurons, into 3D brain organoids, and ultimately into lead compounds. Learn how we generate these cells, the quality control process and also some of the new technologies we are developing in the group for working with 3D neuronal organoids.